Information  X 
Enter a valid email address

Intnl. Biotechnology (IBT)

  Print      Mail a friend

Wednesday 24 December, 2008

Intnl. Biotechnology

Portfolio Update

RNS Number : 7956K
Intl. Biotechnology Trust PLC
24 December 2008
 








24 December 2008




PORTFOLIO COMPANY UPDATE


The Board of International Biotechnology Trust plc (the 'Company') notes the following development within the unquoted portfolio:  


On 23 December 2008, portfolio company Archemix announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop and commercialise aptamer therapeutics to treat inflammatory disease. The terms of the deal provide for a $27.5m upfront payment with a further $200m in milestone-dependent tranches and tiered royalties on worldwide sale if any products result from the alliance. The valuation of the holding in Archemix, totalling £1.2 million (representing 1.1 % of net asset value), has not been changed at this point.

     




Enquiries:


Kate Bingham/David Pinniger

SV Life Sciences Managers LLP          

Investment Manager                                         Tel: 020 7421 7070


Louise Richard

Schroder Investment Management Limited        Tel: 020 7658 6501



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBXBDDGBDGGIS